Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patients-Reference-Cited by-同舟云学术

Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patients

Published:2019-01-17 Issue:3 Volume:102 Page:265-274
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Kondakci Mustafa¹^ORCID,Reinbach Marc C.¹,Germing Ulrich¹,Kobbe Guido¹,Fenk Roland¹,Schroeder Thomas¹,Quader Jasmin¹,Zeus Tobias²,Rassaf Tienush³,Haas Rainer¹

Affiliation:

1. Department of Haematology, Oncology and Clinical Immunology, Medical Faculty University Hospital Duesseldorf Duesseldorf Germany

2. Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty University Hospital Duesseldorf Duesseldorf Germany

3. Department of Cardiology, Medical Faculty University Hospital Essen Essen Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13206

Reference40 articles.

1. Intensive Care, Survival, and Expense of Treating Critically III Cancer Patients

2. Everything thatShouldBe Done—Not Everything thatCanBe Done

3. Impact of case volume on survival of septic shock in patients with malignancies*

4. Continued survival gains in recent years among critically ill myeloma patients

5. Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Prediction Model for 1-Year Mortality in Patients With a Hematologic Malignancy Admitted to the ICU;Critical Care Explorations;2024-05-24

2. Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less;Asia-Pacific Journal of Clinical Oncology;2022-03-14

3. Perspectives on Advance Care Planning for Patients with Hematologic Malignancy: An International Clinician Questionnaire;Annals of the American Thoracic Society;2021-09

4. Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine;Current Drug Targets;2021-02-17

5. Mental health impact of admission to the intensive care unit for COVID-19;British Journal of Community Nursing;2020-11-02